Arterial Hypertension or elevated blood pressure along with cerebral atherosceloris accounts for most deaths across the globe, according to medical statistics. At Cell Malaysia, we offer stem cell therapy which takes care of both these conditions resulting in stabilization of blood pressure and improvement in the condition of arterial walls.
With the treatment here at Cell Malaysia, fetal stem cells of ectodermal and mesenchymal origin are transplanted into the patients with arterial hypertension. The transplant results in the production of different biologically active substances like growth factors, cytokines etc. by getting inside the individual’s cardiac muscles improving the functioning of the heart. Mesenchymal stem cells develop into a phenotype of cardiomyocytes in a microenvironment, restoring the functional properties of the heart muscles.
The FSC brings about a complete restoration of the vascular tissues – including their elasticity, strength and conductivity at a biological level. Some of the positive impacts of the treatment are –
- Improvement in the vascular system
- Partial replacement of destroyed cells
- Enhanced functioning of the cerebral vessel and cardiac blood supply
- Better permeability and elasticity of the blood vessels.
- Better delivery of oxygen and nutritional elements to all other organs and tissues.
Patients have been observed to have a stable decline in blood pressure levels within 3 to 5 months after FSC transplant. These patients have also reported some positive effects of the treatment like reduction in headaches, stable BP, improved mental faculties and sexual potency etc.
Complete disclosure of stem cells’ regenerative potential usually takes place within 2-3 months after the transplant. However, patients are advised to improve their lifestyle by getting rid of habits like smoking, reduce salt intake and increase their physical activities with exercising.